Spinal Bulbar Muscular Atrophy, Kennedy Disease

2017 ◽  
pp. 353-356
Author(s):  
Corrado Angelini
2014 ◽  
Vol 35 (2) ◽  
pp. 443.e1-443.e3 ◽  
Author(s):  
Pietro Fratta ◽  
Toby Collins ◽  
Sally Pemble ◽  
Suran Nethisinghe ◽  
Anny Devoy ◽  
...  

2021 ◽  
Vol 0 (0) ◽  
pp. 0
Author(s):  
Takeo Kosaka ◽  
Hiroshi Hongo ◽  
Hideyuki Hayashi ◽  
Kohei Nakamura ◽  
Hiroshi Nishihara ◽  
...  

2009 ◽  
Vol 40 (5) ◽  
pp. 809-814 ◽  
Author(s):  
Tanya J. Lehky ◽  
Cheun Ju Chen ◽  
Nicholas A. di Prospero ◽  
Lindsay E. Rhodes ◽  
Kenneth Fischbeck ◽  
...  

2001 ◽  
Vol 29 (2) ◽  
pp. 222-227 ◽  
Author(s):  
I. J. McEwan

The androgen receptor is a member of the nuclear receptor superfamily, and regulates gene expression in response to the steroid hormones testosterone and dihydrotestosterone. Mutations in the receptor have been correlated with a diverse range of clinical conditions, including androgen insensitivity, prostate cancer and spinal bulbar muscular atrophy, a neuromuscular degenerative condition. The latter is caused by expansion of a polyglutamine repeat within the N-terminal domain of the receptor. Thus the androgen receptor is one of a growing number of neurodegenerative disease-associated proteins, including huntingtin (Huntington's disease), ataxin-1 (spinocerebellar ataxia, type 1) and ataxin-3 (spinocerebellar ataxia, type 3), which show expansion of CAG triplet repeats. Although widely studied, the functions of huntingtin, ataxin-1 and ataxin-3 remain unknown. The androgen receptor, which has a well-recognized function in gene regulation, provides a unique opportunity to investigate the functional significance of poly(amino acid) repeats in normal and disease states.


2013 ◽  
Vol 47 (6) ◽  
pp. 823-834 ◽  
Author(s):  
Kentaro Oki ◽  
Robert W. Wiseman ◽  
S. Marc Breedlove ◽  
Cynthia L. Jordan

2006 ◽  
Vol 34 (6) ◽  
pp. 1098-1102 ◽  
Author(s):  
J. Duff ◽  
P. Davies ◽  
K. Watt ◽  
I.J. McEwan

The AR (androgen receptor) is a ligand-activated transcription factor that mediates the action of the steroids testosterone and dihydrotestosterone. Alterations in the AR gene result in a number of clinical disorders, including: androgen-insensitivity, which leads to disruption of male development; prostate cancer; and a neuromuscular degenerative condition termed spinal bulbar muscular atrophy or Kennedy's disease. The AR gene is X-linked and the protein is coded for by eight exons, giving rise to a C-terminal LBD (ligand-binding domain; exons 4–8), linked by a hinge region (exon 4) to a Zn-finger DBD (DNA-binding domain; exons 2 and 3) and a large structurally distinct NTD (N-terminal domain; exon 1). Identification and characterization of mutations found in prostate cancer and Kennedy's disease patients have revealed the importance of structural dynamics in the mechanisms of action of receptors. Recent results from our laboratory studying genetic changes in the LBD and the structurally flexible NTD will be discussed.


Sign in / Sign up

Export Citation Format

Share Document